MX9303145A - 7-(2-aminoetil)benzotiazolonas. - Google Patents
7-(2-aminoetil)benzotiazolonas.Info
- Publication number
- MX9303145A MX9303145A MX9303145A MX9303145A MX9303145A MX 9303145 A MX9303145 A MX 9303145A MX 9303145 A MX9303145 A MX 9303145A MX 9303145 A MX9303145 A MX 9303145A MX 9303145 A MX9303145 A MX 9303145A
- Authority
- MX
- Mexico
- Prior art keywords
- independently represent
- benzotiazolonas
- aminoetil
- membered
- halogen
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Ophthalmology & Optometry (AREA)
- Pulmonology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Hospice & Palliative Care (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Cosmetics (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Adhesives Or Adhesive Processes (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Se describen compuestos de la fórmula (I) en donde: X y Y representan independientemente -S(O)n- ó -O- n representan 0, 1 ó 2, p, q, y r, representa independientemente 2 ó 3, z representa fenilo opcionalmente substituído por halógeno, -OR1, -NO2, ó -NR2R3; ó heterociclo que contiene 5 ó 6 miembros de N, O, ó S y R1, R2 y R3 representan independientemente hidrógeno o alquilo de 1 a 6 átomos de carbono, y derivados farmacéuticamente aceptables de los mismos. También se describen procedimientos para su producción, y composiciones farmacéuticamente y métodos de tratamiento que involucran su uso.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB929211172A GB9211172D0 (en) | 1992-05-27 | 1992-05-27 | Compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX9303145A true MX9303145A (es) | 1994-06-30 |
Family
ID=10716059
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX9303145A MX9303145A (es) | 1992-05-27 | 1993-05-27 | 7-(2-aminoetil)benzotiazolonas. |
Country Status (31)
| Country | Link |
|---|---|
| EP (1) | EP0649418B1 (es) |
| JP (1) | JP3094452B2 (es) |
| KR (1) | KR100279132B1 (es) |
| CN (1) | CN1036393C (es) |
| AT (1) | ATE172726T1 (es) |
| AU (1) | AU675649B2 (es) |
| CA (1) | CA2136553C (es) |
| CZ (1) | CZ286905B6 (es) |
| DE (1) | DE69321835T2 (es) |
| DK (1) | DK0649418T3 (es) |
| DZ (1) | DZ1694A1 (es) |
| ES (1) | ES2123652T3 (es) |
| FI (1) | FI945538A (es) |
| GB (1) | GB9211172D0 (es) |
| HU (2) | HUT71124A (es) |
| IL (1) | IL105801A (es) |
| LV (1) | LV12443B (es) |
| MA (1) | MA22895A1 (es) |
| MX (1) | MX9303145A (es) |
| MY (1) | MY131193A (es) |
| NO (1) | NO304739B1 (es) |
| NZ (1) | NZ253190A (es) |
| PH (1) | PH31453A (es) |
| PL (2) | PL172904B1 (es) |
| RU (1) | RU2114108C1 (es) |
| SG (1) | SG48068A1 (es) |
| SK (1) | SK281282B6 (es) |
| TW (1) | TW368501B (es) |
| UA (1) | UA27901C2 (es) |
| WO (1) | WO1993024473A1 (es) |
| ZA (1) | ZA933648B (es) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW356468B (en) * | 1995-09-15 | 1999-04-21 | Astra Pharma Prod | Benzothiazolone compounds useful as beta2-adrenoreceptor and dopamine DA2 receptor agonists process for preparing same and pharmaceutical compositions containing same |
| GB9526511D0 (en) * | 1995-12-23 | 1996-02-28 | Astra Pharma Prod | Pharmaceutically active compounds |
| SE9900693D0 (sv) * | 1999-02-26 | 1999-02-26 | Astra Pharma Prod | Novel process |
| SE9902937D0 (sv) * | 1999-08-18 | 1999-08-18 | Astra Pharma Prod | Pharmaceutical compositions |
| SE9902938D0 (sv) * | 1999-08-18 | 1999-08-18 | Astra Pharma Prod | Pharmaceutical compositions |
| SE9902935D0 (sv) * | 1999-08-18 | 1999-08-18 | Astra Pharma Prod | Pharmaceutical compositions |
| SE9902936D0 (sv) * | 1999-08-18 | 1999-08-18 | Astra Pharma Prod | Pharmaceutical compositions |
| DE10063957A1 (de) * | 2000-12-20 | 2002-06-27 | Boehringer Ingelheim Pharma | Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und Dopamin-Agonisten |
| AR040962A1 (es) * | 2002-08-09 | 2005-04-27 | Novartis Ag | Compuestos derivados de tiazol 1,3-2-ona, composicion farmaceutica y proceso de preparacion del compuesto |
| GB0218629D0 (en) * | 2002-08-09 | 2002-09-18 | Novartis Ag | Organic compounds |
| CA2543858C (en) | 2003-11-21 | 2014-04-15 | Theravance, Inc. | Compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity |
| GB0426164D0 (en) | 2004-11-29 | 2004-12-29 | Novartis Ag | Organic compounds |
| TW200738658A (en) | 2005-08-09 | 2007-10-16 | Astrazeneca Ab | Novel compounds |
| TW200738659A (en) * | 2005-08-29 | 2007-10-16 | Astrazeneca Ab | Novel compounds |
| TW200745067A (en) | 2006-03-14 | 2007-12-16 | Astrazeneca Ab | Novel compounds |
| RU2455295C2 (ru) * | 2006-12-20 | 2012-07-10 | АстраЗенека AБ | 4-ГИДРОКСИ-2-ОКСО-2,3-ДИГИДРО-1,3-БЕНЗОТИАЗОЛ-7-ИЛЬНЫЕ СОЕДИНЕНИЯ ДЛЯ МОДУЛЯЦИИ β2-АДРЕНОРЕЦЕПТОРНОЙ АКТИВНОСТИ |
| TW200833670A (en) | 2006-12-20 | 2008-08-16 | Astrazeneca Ab | Novel compounds 569 |
| GB0702458D0 (en) | 2007-02-08 | 2007-03-21 | Astrazeneca Ab | Salts 668 |
| GB0704000D0 (en) * | 2007-03-01 | 2007-04-11 | Astrazeneca Ab | Salts 670 |
| KR20110017456A (ko) | 2008-06-18 | 2011-02-21 | 아스트라제네카 아베 | 호흡기 장애의 치료를 위한 베타2-아드레날린성 수용체 효능제로서 작용하는 벤족사지논 유도체 |
| CN102977050B (zh) * | 2012-11-20 | 2015-04-22 | 浙江工业大学 | 一种2-苯并噻唑二甲缩醛和2-苯并噻唑甲醛的合成方法 |
| CN106748930B (zh) * | 2016-12-05 | 2019-03-15 | 三门峡奥科化工有限公司 | 3-巯基-1-丙醇的制备方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4554284A (en) * | 1984-09-12 | 1985-11-19 | Smithkline Beckman Corporation | 7-(2-Aminoethyl)-1,3-benzthia- or oxa-zol-2(3H)-ones |
| IE914003A1 (en) * | 1990-11-20 | 1992-05-20 | Astra Pharma Prod | Biologically Active Amines |
-
1992
- 1992-05-27 GB GB929211172A patent/GB9211172D0/en active Pending
-
1993
- 1993-05-05 PH PH46233A patent/PH31453A/en unknown
- 1993-05-25 ZA ZA933648A patent/ZA933648B/xx unknown
- 1993-05-25 IL IL10580193A patent/IL105801A/xx not_active IP Right Cessation
- 1993-05-26 TW TW082104181A patent/TW368501B/zh active
- 1993-05-26 MA MA23194A patent/MA22895A1/fr unknown
- 1993-05-26 DZ DZ930063A patent/DZ1694A1/fr active
- 1993-05-27 CA CA002136553A patent/CA2136553C/en not_active Expired - Fee Related
- 1993-05-27 CZ CZ19942916A patent/CZ286905B6/cs not_active IP Right Cessation
- 1993-05-27 RU RU94046093A patent/RU2114108C1/ru active
- 1993-05-27 MX MX9303145A patent/MX9303145A/es not_active IP Right Cessation
- 1993-05-27 AU AU43343/93A patent/AU675649B2/en not_active Ceased
- 1993-05-27 EP EP93913203A patent/EP0649418B1/en not_active Expired - Lifetime
- 1993-05-27 PL PL93306303A patent/PL172904B1/pl unknown
- 1993-05-27 SK SK1433-94A patent/SK281282B6/sk unknown
- 1993-05-27 SG SG1996006829A patent/SG48068A1/en unknown
- 1993-05-27 HU HU9403387A patent/HUT71124A/hu unknown
- 1993-05-27 ES ES93913203T patent/ES2123652T3/es not_active Expired - Lifetime
- 1993-05-27 PL PL93317714A patent/PL172807B1/pl unknown
- 1993-05-27 MY MYPI93000997A patent/MY131193A/en unknown
- 1993-05-27 NZ NZ253190A patent/NZ253190A/en unknown
- 1993-05-27 AT AT93913203T patent/ATE172726T1/de not_active IP Right Cessation
- 1993-05-27 UA UA94119105A patent/UA27901C2/uk unknown
- 1993-05-27 JP JP06500327A patent/JP3094452B2/ja not_active Expired - Fee Related
- 1993-05-27 DE DE69321835T patent/DE69321835T2/de not_active Expired - Fee Related
- 1993-05-27 DK DK93913203T patent/DK0649418T3/da active
- 1993-05-27 WO PCT/GB1993/001095 patent/WO1993024473A1/en active IP Right Grant
- 1993-05-27 CN CN93108209A patent/CN1036393C/zh not_active Expired - Fee Related
- 1993-05-27 KR KR1019940704294A patent/KR100279132B1/ko not_active IP Right Cessation
-
1994
- 1994-11-24 NO NO944509A patent/NO304739B1/no not_active IP Right Cessation
- 1994-11-25 FI FI945538A patent/FI945538A/fi unknown
-
1995
- 1995-06-27 HU HU95P/P00462P patent/HU211947A9/hu unknown
-
1999
- 1999-10-28 LV LVP-99-152A patent/LV12443B/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2123652T3 (es) | 7-(2-aminoetil)-benzotiazolonas. | |
| HUP0101999A2 (hu) | 4-Hidroxi-kinolin-3-karboxamid- és -hidrazid-származékok, ezeket tartalmazó gyógyászati készítmények, valamint e vegyületek alkalmazása | |
| DK0683789T3 (da) | N-alkyl-2-substituerede ATP-analoger | |
| FI913478A0 (fi) | Diazinderivat. | |
| NO882036D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske ketoner. | |
| NO304379B1 (no) | 11,21-bisfenyl-19-norpregnan-derivater, anvendelse derav og farmas°ytiske preparater inneholdende slike derivater | |
| DK0587088T3 (da) | Substituerede cyclohexan-derivater, fremgangsmåde til deres fremstilling og anvendelsen af forbindelserne til behandling af sygdomme | |
| ATE170852T1 (de) | Benzolsulfonamid-derivate zur behandlung der blaseninstabilität | |
| DK0446141T3 (da) | Imidazo(1,2-c)quinazolinderivater og fremgangsmåde til fremstilling deraf samt farmaceutiske midler indeholdende dem | |
| DE69330601D1 (de) | Serotoninergische ergolin derivate | |
| DK283984D0 (da) | Benzodiazepinderivater og fremgangsmaade til fremstilling deraf | |
| DE69619088D1 (de) | Quinoxalin-Derivate zur Behandlung von Tinnitus | |
| ATE1585T1 (de) | Clavulansaeurederivate, ihre herstellung und sie enthaltende pharmazeutische praeparate. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration | ||
| GB | Transfer or rights | ||
| PD | Change of proprietorship |
Owner name: ASTRAZENECA AB |
|
| MM | Annulment or lapse due to non-payment of fees |